Juan Esteban Garcia-Robledo

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Venues

The application of clinical genetics

JCO global oncology

Hematology reports

Journal of medical case reports

Fundación Valle del Lili

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fundación Valle del Lili Oct 01 2019

Colombia

Research Fellow :: Hematology/Oncology

Centro Médico Julián Coronel Jan 04 2019

Colombia

Clinical Researcher

Universidad Icesi Apr 01 2019 - Dec 15 2019

Colombia

Associate Professor

Publications

Carolina Sotelo-Rodríguez, Dora Lucia Vallejo Ardila, Alejandro Ruíz-Patiño, Diego F Chamorro, July Rodríguez, Darwin A Moreno-Pérez, Hernán Carranza, Jorge Otero, Carlos Vargas, Pilar Archila, Leonardo Rojas, Jairo Zuluaga, Cladelis Rubio, Camila Ordóñez-Reyes, Juan Esteban Garcia-Robledo, Sergio Mejía, Elvira Jaller, Arrieta Oscar, Andrés F Cardona
Molecular Tumor Board Improves Outcomes for Hispanic Patients With Advanced Solid Tumors. JCO global oncology 10 (2024)
Carolina Sotelo-Rodríguez, Dora Lucia Vallejo Ardila, Alejandro Ruíz-Patiño, Diego F Chamorro, July Rodríguez, Darwin A Moreno-Pérez, Hernán Carranza, Jorge Otero, Carlos Vargas, Pilar Archila, Leonardo Rojas, Jairo Zuluaga, Cladelis Rubio, Camila Ordóñez-Reyes, Juan Esteban Garcia-Robledo, Sergio Mejía, Elvira Jaller, Arrieta Oscar, Andrés F Cardona
Molecular Tumor Board Improves Outcomes for Hispanic Patients With Advanced Solid Tumors. JCO global oncology 10 (2024)
Carolina Sotelo-Rodríguez, Dora Lucia Vallejo Ardila, Alejandro Ruíz-Patiño, Diego F Chamorro, July Rodríguez, Darwin A Moreno-Pérez, Hernán Carranza, Jorge Otero, Carlos Vargas, Pilar Archila, Leonardo Rojas, Jairo Zuluaga, Cladelis Rubio, Camila Ordóñez-Reyes, Juan Esteban Garcia-Robledo, Sergio Mejía, Elvira Jaller, Arrieta Oscar, Andrés F Cardona
Molecular Tumor Board Improves Outcomes for Hispanic Patients With Advanced Solid Tumors. JCO global oncology 10 (2024)
Maheswari Eluru, Daniel Hector Mendoza, Audrey Wong, Mohammad Jafari, Michael Todd, Patricia Bayless, Darwyn Chern, Christina Eldredge, Rodrigo Fonseca, Pedro Franco-Fuquen, Juan Esteban Garcia-Robledo, Benjamin Grant Gifford, Rhea Hans, Eider Felipe Moreno-Cortes, Ajay Perumbeti, Fabio Samir Vargas-Cely, Lin Zhao, Maria Adela Grando
Physicians' Perspectives on HL7 Information Policy Sensitive Value Set: A Validation Study through Health Concept Categorization. Healthcare (Basel, Switzerland) 11 (21) (2023)
Lisa Ximena Rodriguez-Rojas, Estephania Candelo, Harry Pachajoa, Juan Esteban Garcia-Robledo, José Antonio Nastasi-Catanese, Jorge Andres Olave-Rodriguez, Angela R Zambrano
The Unique Spectrum of MUTYH Germline Mutations in Colombian Patients with Extracolonic Carcinomas. The application of clinical genetics 16 (2023)
Lisa Ximena Rodriguez-Rojas, Estephania Candelo, Harry Pachajoa, Juan Esteban Garcia-Robledo, José Antonio Nastasi-Catanese, Jorge Andres Olave-Rodriguez, Angela R Zambrano
The Unique Spectrum of MUTYH Germline Mutations in Colombian Patients with Extracolonic Carcinomas. The application of clinical genetics 16 (2023)
Lisa Ximena Rodriguez-Rojas, Estephania Candelo, Harry Pachajoa, Juan Esteban Garcia-Robledo, José Antonio Nastasi-Catanese, Jorge Andres Olave-Rodriguez, Angela R Zambrano
The Unique Spectrum of MUTYH Germline Mutations in Colombian Patients with Extracolonic Carcinomas. The application of clinical genetics 16 (2023)
Lisa Ximena Rodriguez-Rojas, Estephania Candelo, Harry Pachajoa, Juan Esteban Garcia-Robledo, José Antonio Nastasi-Catanese, Jorge Andres Olave-Rodriguez, Angela R Zambrano
The Unique Spectrum of MUTYH Germline Mutations in Colombian Patients with Extracolonic Carcinomas. The application of clinical genetics 16 (2023)
Juan Esteban Garcia-Robledo, Cristina Valencia-Sanchez, Molly G Knox, Brent P Goodman, Allison C Rosenthal, Bhavesh Patel, Januario E Castro
It Is in the Eye of the Beholder: Ocular Ultrasound Enhanced Monitoring of Neurotoxicity after CAR-T Cell Therapy. Hematology reports 15 (1) (2022)
Camila Ordóñez-Reyes, Juan Esteban Garcia-Robledo, Diego Fernando Chamorro Ortiz, Andrés Mosquera, Liliana Sussmann, Alejandro Ruiz-Patiño, Oscar Arrieta, Lucia Zatarain-Barrón, Leonardo Rojas, Alessandro Russo, Diego de Miguel Pérez, Christian Rolfo, Andrés F Cardona
Bispecific Antibodies in Cancer Immunotherapy: A Novel Response to an Old Question. Pharmaceutics 14 (6) (2022)
Januario E Castro, Paula A Lengerke-Diaz, Juliana Velez Lujan, Michael Y Choi, Eider Felipe Moreno-Cortes, Jose V Forero, Juan Esteban Garcia-Robledo, Chaja Jacobs, Colin McCarthy, Alaina Heinen, Carlos I Amaya-Chanaga, Thomas J Kipps
Ibrutinib plus Obinutuzumab as Frontline Therapy for Chronic Lymphocytic Leukemia Is Associated with a Lower Rate of Infusion-Related Reactions and with Sustained Remissions after Ibrutinib Discontinuation: A Single-Arm, Open-Label, Phase 1b/2 Clinical Trial NCT0231576. Advances in hematology 2022 (2022)
Juan Esteban Garcia-Robledo, Cristina Valencia-Sanchez, Molly G Knox, Brent P Goodman, Allison C Rosenthal, Bhavesh Patel, Januario E Castro
It Is in the Eye of the Beholder: Ocular Ultrasound Enhanced Monitoring of Neurotoxicity after CAR-T Cell Therapy. Hematology reports 15 (1) (2022)
Andrés Felipe Cardona, Camila Ordóñez-Reyes, Alejandro Ruíz-Patiño, Juan Esteban Garcia-Robledo, Lucia Zatarain Barron, Gonzalo Recondo, Leonardo Rojas, Luis Corrales-Rodríguez, Claudio Marcelo Martin, Feliciano Barrón, Carolina Sotelo-Rodríguez, July Rodríguez, Luisa Ricaurte, Christian C Rolfo, Jenny Ávila, Diana Mayorga, Pilar Archila, Jorge Otero, Luis Mas, Maritza Bermudez, Tatiana Gamez, Hernán Carranza, Carlos Vargas, Rafael Rosell, Arrieta Oscar
EGFR Inhibitors Plus Bevacizumab are Superior Than EGFR Inhibitors Alone as First-Line Setting in Advanced NSCLC With EGFR Mutations and BIM Deletion Polymorphisms (BIM-CLICaP). JCO precision oncology 5 (2022)
Juan Esteban Garcia-Robledo, Cristina Valencia-Sanchez, Molly G Knox, Brent P Goodman, Allison C Rosenthal, Bhavesh Patel, Januario E Castro
It Is in the Eye of the Beholder: Ocular Ultrasound Enhanced Monitoring of Neurotoxicity after CAR-T Cell Therapy. Hematology reports 15 (1) (2022)
Juan Esteban Garcia-Robledo, Rafael Rosell, Alejandro Ruíz-Patiño, Carolina Sotelo, Oscar Arrieta, Lucia Zatarain-Barrón, Camila Ordoñez, Elvira Jaller, Leonardo Rojas, Alessandro Russo, Diego de Miguel-Pérez, Christian Rolfo, Andrés Felipe Cardona
KRAS and MET in non-small-cell lung cancer: two of the new kids on the 'drivers' block. Therapeutic advances in respiratory disease 16 (2022)
Estefania Beltran, Juan Esteban Garcia-Robledo, Lisa X Rodríguez-Rojas, Martin Rengifo, Bladimir Perez, Harry Pachajoa, Angela R Zambrano
Clear cell renal carcinoma synchronous with dedifferentiated liposarcoma: a case report and review of the literature. Journal of medical case reports 14 (1) (2020)
Juan Esteban Garcia-Robledo, María Claudia Barrera, Gabriel J Tobón
CRISPR/Cas: from adaptive immune system in prokaryotes to therapeutic weapon against immune-related diseases. International reviews of immunology 39 (1) (2019)

Juan Esteban Garcia-Robledo.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Juan Esteban Garcia-Robledo